Corynantheidine
(Synonyms: (-)-Corynantheidine, 9-demethoxy Mitragynine) 目录号 : GC52243An alkaloid with antinociceptive activity
Cas No.:23407-35-4
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Corynantheidine is an alkaloid that has been found in M. speciosa (Kratom in Thai) and has antinociceptive activity.1,2 It is a partial agonist of the μ-opioid receptor that lacks β-arrestin recruitment activity.1 Corynantheidine selectively binds to μ-opioid receptors over κ- and δ-opioid receptors (Kis = 57.1, 385.4, and 172 nM, respectively, for the mouse receptors) and is selective for the μ-opioid receptor (EC50 = 104.24 nM) over the κ- and δ-opioid receptors, for which it has no activity, in [35S]GTPγS assays. It also binds to α1D- and α2A-adrenergic receptors and NMDA receptors (Kis = 41, 74, and 83 nM, respectively, for the human receptors), among others.1,2 Corynantheidine (10-100 nmol, i.c.v.) increases the latency to tail withdrawal in the tail-flick test in mice.1
1.Chakraborty, S., Uprety, R., Daibani, A.E., et al.Kratom alkaloids as probes for opioid receptor function: Pharmacological characterization of minor indole and oxindole alkaloids from kratomACS Chem. Neurosci.12(14)2661-2678(2021) 2.Obeng, S., Kamble, S.H., Reeves, M.E., et al.Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloidsJ. Med. Chem.63(1)433-439(2020)
Cas No. | 23407-35-4 | SDF | Download SDF |
别名 | (-)-Corynantheidine, 9-demethoxy Mitragynine | ||
Canonical SMILES | CC[C@@H]1CN2[C@@](C(NC3=CC=CC=C34)=C4CC2)([H])C[C@@H]1/C(C(OC)=O)=C\OC | ||
分子式 | C22H28N2O3 | 分子量 | 368.5 |
溶解度 | DMF: 1 mg/ml,DMSO: 2 mg/ml,Ethanol: insol,PBS (pH 7.2): insol | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.7137 mL | 13.5685 mL | 27.137 mL |
5 mM | 0.5427 mL | 2.7137 mL | 5.4274 mL |
10 mM | 0.2714 mL | 1.3569 mL | 2.7137 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。